Skip to main content
Toggle navigation
Menu
Overall search
Search ClinicalINFO
In affiliation with
HIV.gov
Search
Close
Main navigation
Home
About
Guidelines
Drug Database
Glossary
News
Resources
Contact Us
English
Toggle Dropdown
English
Español (Spanish)
Home
Search Results
Overall search
Search ClinicalINFO
Search Results
3241 – 3260
of
3979
Hepatitis C Virus
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/hepatitis-c-virus
Preventing Vaccine-Preventable Diseases in Children and Adolescents With HIV Infection
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/preventing-vaccine-preventable-diseases
Stavudine (Zerit, d4T)
https://clinicalinfo.hiv.gov/guidelines/perinatal/archived-drugs-stavudine-zerit
Efavirenz (Sustiva, EFV)
https://clinicalinfo.hiv.gov/guidelines/perinatal/safety-toxicity-arv-agents-nnrtis-efavirenz-sustiva
Appendix C. Panel Members
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/appendix-panel-roster
Elvitegravir
https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/elvitegravir
Cryptosporidiosis
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/cryptosporidiosis
Raltegravir
https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/raltegravir
Histoplasmosis
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/histoplasmosis
Chagas Disease
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/chagas-disease
Drug-Drug Interactions: CCR5 Antagonist and Other Drugs
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/drug-interactions-ccr5-antagonist
Ibalizumab-uiyk (Trogarzo, IBA)
https://clinicalinfo.hiv.gov/guidelines/perinatal/safety-toxicity-arv-agents-entry-attachment-inhibitors-ibalizumab-uiyk-trogarzo
Darunavir
https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/darunavir
Antiretroviral Management of Newborns With Perinatal HIV Exposure or HIV Infection
https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/antiretroviral-management-newborns-perinatal-hiv-exposure-or-hiv-infection
Appendix B: Bacterial Enteric Infections
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/appendix-b-0
Human Papillomavirus Disease
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/human
Appendix C: Antiretroviral Medications that Can Be Switched Temporarily Due to Supply Shortage
https://clinicalinfo.hiv.gov/guidelines/guidelines-caring-persons-hiv-disaster-areas/appendix-c-antiretroviral-medications-can
Maraviroc (Selzentry, MVC)
https://clinicalinfo.hiv.gov/guidelines/perinatal/safety-toxicity-arv-agents-entry-attachment-inhibitors-maraviroc-selzentry
Disseminated Mycobacterium avium Complex Disease
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/disseminated
Mycobacterium avium Complex Disease
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/mycobacterium-avium-complex
Pagination
First page
«
Previous page
‹
…
Page
159
Page
160
Page
161
Page
162
Current page
163
Page
164
Page
165
Page
166
Page
167
…
Next page
›
Last page
»